CHM chimeric therapeutics limited

This is probably the better benchmark for this trial,...

  1. 8,324 Posts.
    lightbulb Created with Sketch. 3661
    This is probably the better benchmark for this trial, notwithstanding that it will be the depth of response (the durability) that will be the point of difference that CORE NK is expected to add. This is a quick summary that Grok puts forth:

    https://hotcopper.com.au/data/attachments/7002/7002436-85f9f17184acf7ee37b28ef3cc425228.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.